Gilead Wins $14M In Attys' Fees For Merck Patent Misconduct
A California federal judge on Friday ordered Merck & Co. Inc. to pay Gilead Sciences Inc. $14 million in attorneys' fees after finding last year that Merck committed "numerous unconscionable acts"...To view the full article, register now.
Already a subscriber? Click here to view full article